Bexmarilimab (FP-1305) is a highly potent humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM. Bexmarilimab promotes immune conversion of tumor-associated macrophage phenotype M2 to M1. Bexmarilimab can be used to study cancer.
CAS Number:
[2259301-27-2]
Target:
FP-1305
* VAT and and shipping costs not included. Errors and price changes excepted